Literature DB >> 22693187

Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant.

Alan Martin Edwards1, Stepánka Capková.   

Abstract

Diffuse cutaneous mastocytosis (DCM) is a rare, severe, variant of cutaneous mastocytosis. The authors report the case of a male infant who developed maculae and maculopapulae on his legs and abdomen when aged 3.5 months, which spread to all body surfaces within weeks. Diagnosis of DCM was made at the age of 6 months when he had developed extensive bullous eruptions, generalised pruritus, flushing and abdominal pain. Treatment was started with oral dimethindine maleate. At the age of 18 months, oral sodium cromoglicate (SCG) was introduced. At the age of 23 months, additional treatment was started with a cutaneous emulsion containing 4% SCG. Continued treatment with oral dimethindine maleate, oral SCG with the dose maintained at 25 mg/kg/day, and SCG 4% cutaneous emulsion applied two to four times daily has resulted in a steady improvement of symptoms and skin appearance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22693187      PMCID: PMC3128352          DOI: 10.1136/bcr.02.2011.3910

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.

Authors:  R Stainer; S Matthews; S H Arshad; S McDonald; J Robinson; C Schapira; K D Foote; M Baird-Snell; T Gregory; I Pollock; M T Stevens; A M Edwards
Journal:  Br J Dermatol       Date:  2005-02       Impact factor: 9.302

2.  [Bullous mastocytosis in a child].

Authors:  U F Haustein; M Bedri
Journal:  Hautarzt       Date:  1997-02       Impact factor: 0.751

3.  Cromolyn sodium in the management of systemic mastocytosis.

Authors:  R F Horan; A L Sheffer; K F Austen
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

4.  Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations.

Authors:  F L Pearce; M Al-Laith; L Bosman; J Brostoff; T M Cunniffe; K C Flint; B N Hudspith; Z H Jaffar; N M Johnson; T A Kassessinoff
Journal:  Drugs       Date:  1989       Impact factor: 9.546

5.  Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha.

Authors:  L J Walsh
Journal:  Immunol Cell Biol       Date:  1995-06       Impact factor: 5.126

6.  Diffuse cutaneous mastocytosis mimicking staphylococcal scalded-skin syndrome: report of three cases.

Authors:  A P Oranje; W Soekanto; A Sukardi; V D Vuzevski; A van der Willigen; H M Afiani
Journal:  Pediatr Dermatol       Date:  1991-06       Impact factor: 1.588

Review 7.  Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.

Authors:  I Silva; S Carvalho; P L Pinto; S Machado; J Rosado Pinto
Journal:  Allergol Immunopathol (Madr)       Date:  2008 May-Jun       Impact factor: 1.667

8.  Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine.

Authors:  Y Okayama; R C Benyon; P H Rees; M A Lowman; K Hillier; M K Church
Journal:  Clin Exp Allergy       Date:  1992-03       Impact factor: 5.018

9.  The effect of intravenous sodium cromoglycate on the bronchoconstriction induced by sulphur dioxide inhalation in man.

Authors:  A Allistone; J G Collier; R N Davidson; R W Fuller; P S Richardson
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

10.  Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial.

Authors:  M Frieri; D W Alling; D D Metcalfe
Journal:  Am J Med       Date:  1985-01       Impact factor: 4.965

View more
  8 in total

Review 1.  Mastocytosis in Children.

Authors:  Nicholas Klaiber; Santhosh Kumar; Anne-Marie Irani
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-07       Impact factor: 4.806

2.  Cutaneous Mastocytosis with Persistent Blistering: Successful Treatment with Methylprednisolone and 3-Year Follow-Up Management.

Authors:  Rumyana Yankova; Tsvetana Abadjieva; Veselin Belovezhdov
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-15

Review 3.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

4.  Diffuse cutaneous mastocytosis with novel somatic KIT mutation K509I and association with tuberous sclerosis.

Authors:  Iris M Otani; Ryan W Carroll; Phoebe Yager; Daniela Kroshinsky; Sarah Murphy; Jason L Hornick; Cem Akin; Mariana Castells; Jolan E Walter
Journal:  Clin Case Rep       Date:  2018-07-31

5.  The Evaluation of Concentration - In-Vitro Release Relationship for Topical Semisolid Formulations of Sodium Cromoglycate.

Authors:  A A Stănescu
Journal:  Curr Health Sci J       Date:  2015-12-22

6.  Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome.

Authors:  Iolanda Conde-Fernandes; Rita Sampaio; Filipa Moreno; José Palla-Garcia; Maria Dos Anjos Teixeira; Inês Freitas; Esmeralda Neves; Maria Jara-Acevedo; Luis Escribano; Margarida Lima
Journal:  Allergy Asthma Clin Immunol       Date:  2017-04-24       Impact factor: 3.406

Review 7.  Mastocytosis: from a Molecular Point of View.

Authors:  Daniel Elieh Ali Komi; Todd Rambasek; Stefan Wöhrl
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 8.  Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Authors:  Magdalena Lange; Karin Hartmann; Melody C Carter; Frank Siebenhaar; Ivan Alvarez-Twose; Inés Torrado; Knut Brockow; Joanna Renke; Ninela Irga-Jaworska; Katarzyna Plata-Nazar; Hanna Ługowska-Umer; Justyna Czarny; Anna Belloni Fortina; Francesca Caroppo; Roman J Nowicki; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.